JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5776
Battalion Oil
BATL
$60.1M
| $15K | ﹤0.01% |
2,266
+783
| +53% | +$7.28K |
2020 Q1
12 quarters
|
|
5777
Citizens Financial Services
CZFS
$382M
| $15K | ﹤0.01% |
189
| – | – |
2022 Q2
3 quarters
|
|
5778
Invesco S&P International Developed Low Volatility ETF
IDLV
$317M
| $15K | ﹤0.01% |
533
| – | – |
2017 Q4
21 quarters
|
|
5779
Invesco International Developed Dynamic Multifactor ETF
IMFL
$1.06B
| $15K | ﹤0.01% |
+660
| New | +$14.8K |
2023 Q1
0 quarters
|
|
|
ISPO
5780
DELISTED
Inspirato
ISPO
| $15K | ﹤0.01% |
786
+85
| +12% | +$1.97K |
2022 Q2
3 quarters
|
|
|
JHI
5781
John Hancock Investors Trust
JHI
$105M
| $15K | ﹤0.01% |
+1,190
| New | +$15.4K |
2023 Q1
0 quarters
|
|
5782
CALL
Nerdy
NRDY
$58.6M
| $15K | ﹤0.01% |
+247
| New | +$11.3K |
2023 Q1
0 quarters
|
|
5783
OppFi
OPFI
$515M
| $15K | ﹤0.01% |
7,377
-2,038
| -22% | -$4.28K |
2021 Q3
6 quarters
|
|
|
RPTX
5784
DELISTED
Repare Therapeutics
RPTX
| $15K | ﹤0.01% |
1,479
+29
| +2% | +$333 |
2020 Q4
9 quarters
|
|
|
VFL
5785
DELISTED
abrdn National Municipal Income Fund
VFL
| $15K | ﹤0.01% |
+1,402
| New | +$15K |
2023 Q1
0 quarters
|
|
|
FAM
5786
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
| $15K | ﹤0.01% |
+2,485
| New | +$14.8K |
2023 Q1
0 quarters
|
|
|
FATH
5787
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $15K | ﹤0.01% |
1,416
+1,082
| +324% | +$25.2K |
2022 Q1
4 quarters
|
|
|
AUD
5788
DELISTED
Audacy, Inc.
AUD
| $15K | ﹤0.01% |
118,878
+37,581
| +46% | +$8.64K |
2013 Q2
39 quarters
|
|
|
ATIP
5789
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $15K | ﹤0.01% |
1,152
+300
| +35% | +$5.46K |
2022 Q2
3 quarters
|
|
5790
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.27B
| $14.7K | ﹤0.01% |
314
-662
| -68% | -$30.7K |
2022 Q3
2 quarters
|
|
|
EDD
5791
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$338M
| $14K | ﹤0.01% |
+3,136
| New | +$14.3K |
2023 Q1
0 quarters
|
|
|
ALLK
5792
DELISTED
Allakos
ALLK
| $14K | ﹤0.01% |
3,130
-72,806
| -96% | -$466K |
2018 Q3
18 quarters
|
|
5793
BlackRock Intermediate Muni Income Bond ETF
INMU
$656M
| $14K | ﹤0.01% |
600
-399,890
| -100% | -$9.39M |
2022 Q4
1 quarter
|
|
5794
Ideal Power
IPWR
$64.9M
| $14K | ﹤0.01% |
1,307
+7
| +0.5% | +$81 |
2022 Q1
4 quarters
|
|
5795
LCNB Corp
LCNB
$270M
| $14K | ﹤0.01% |
882
-15
| -2% | -$267 |
2017 Q4
21 quarters
|
|
|
LNAI
5796
Lunai Bioworks
LNAI
$5.17M
| $14K | ﹤0.01% |
189
+49
| +35% | +$4.31K |
2022 Q2
3 quarters
|
|
|
SHCO
5797
DELISTED
Soho House & Co
SHCO
| $14K | ﹤0.01% |
2,136
| – | – |
2021 Q3
6 quarters
|
|
5798
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$731M
| $14K | ﹤0.01% |
400
-79,500
| -99% | -$1.6M |
2021 Q2
7 quarters
|
|
|
SEEL
5799
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $14K | ﹤0.01% |
+5
| New | +$14.6K |
2022 Q3
2 quarters
|
|
|
CEM
5800
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
| $14K | ﹤0.01% |
444
-36
| -8% | -$1.23K |
2022 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.